Autopsy report · NCT00460278

Study of XL418 in Adults With Solid Tumors

“Enrollment suspended due to low drug exposure.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 63 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1

Sponsor

Exelixis

Sponsor type

Industry

Conditions

Cancer; Solid Tumors

Interventions

XL418

Participants

63 (planned, not actual)

Sites

2

Countries

United States

Trials that died the same way

• Dopamine Rhythms in Health and Addiction
  “No enrollment, delay with drug availability.” (72% match in meaning)
• MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
  “Funding suspended prior to completing enrollment of all participants.” (70% match in meaning)
• A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema
  “Halted prematurely due to low enrollment” (67% match in meaning)
• Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
  “Study Suspended. Slow enrollment.” (66% match in meaning)
• Intraocular Pressure (IOP) Changes Associated With Muslim Prayer Postural Changes
  “Stopped due to low enrollment” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.